SPAC raises $30M via over-allotment; trust now $231.15M

Drugs Made In America Acquisition Corp.

Underwriters exercised over-allotment option in full on Feb 18, 2025; 3M additional units at $10/unit raised $30M.
Sponsor purchased 30K additional private placement units for $300K, bringing total private units to 430K.
Total trust account now holds $231.15M from IPO, over-allotment, and private placement proceeds.
1,285,714 founder shares are no longer subject to forfeiture due to over-allotment exercise.
Underwriters received 30K representative shares issued in connection with the over-allotment.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.